913689-08-4Relevant articles and documents
Fat mass and obesity-associated protein (FTO) inhibitors prepared from 9-(2-carboxyphenyl) xanthene compounds and therapeutic effects thereof
-
Paragraph 0055-0058; 0062-0064, (2020/07/13)
The invention relates to usage of the following general formula I as a drug for diseases targeting fat mass and obesity-associated protein (FTO), and provides usage of 9-(2-carboxyphenyl) xanthene compounds in preparation of FTO inhibitors. Specifically, the invention discloses usage of the 9-(2-carboxyphenyl) xanthene compounds as shown in the formula (I), as well as derivatives and pharmaceutically acceptable salts thereof, in preparation of the FTO inhibitors or pharmaceutical compositions for treating FTO-related diseases.
SULFONATE COMPOUND AND FLUORESCENT PROBE USING THE SAME
-
Page/Page column 21-22, (2008/06/13)
The present invention provides a sulfonate compound, including a structure represented by a general formula (I) below, where, in the formula (I), an atomic group A-O is an atomic group that forms a fluorescent compound upon cleavage of a covalent bond between the atomic group A-O and a sulfonyl group, one or a plurality of atomic groups B-SO3- are bonded to an atomic group A, B is a ring that is substituted by one or a plurality of electron-withdrawing groups, the electron-withdrawing group is at least one selected from the group consisting of an alkyl halide group, a nitro group and a cyano group, and B may be the same or different in kind in the case where the plurality of B exist.
A design of fluorescent probes for superoxide based on a nonredox mechanism
Maeda, Hatsuo,Yamamoto, Kayoko,Nomura, Yoko,Kohno, Iho,Hafsi, Leila,Ueda, Noritsugu,Yoshida, Shoko,Fukuda, Masako,Fukuyasu, Yuka,Yamauchi, Yuji,Itoh, Norio
, p. 68 - 69 (2007/10/03)
Fluorometric detection of O2-? is performed based on desulfonylation of 3 to the corresponding fluoresceins 4 through nucleophilic substitution, and this fluorescing process is quite specific toward O2-? over H